As of November 6, 2026, Beam Therapeutics Inc. is a publicly traded company (Nasdaq: BEAM); its largest reported holder is Fidelity (FMR), with 12.6% on Schedule 13G/A of February 5, 2026, then Farallon Capital Management, L.L.C. (9.99%) (Schedule 13G/A, February 5, 2026).
Is this your company?
About to sign with, pay or invest in Beam Therapeutics Inc.? See the free Snapshot first.
Free to see. No signup.
Is Beam Therapeutics Inc. a real, registered company?
- Beam Therapeutics Inc. files with the SEC under CIK 1745999 (its SEC filings).
- Its shares are listed under the ticker BEAM on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Cambridge, Massachusetts, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Beam Therapeutics Inc. in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names ARK Invest (filed 2026-08-14).
Who are Beam Therapeutics Inc.'s owners and officers?
Beam Therapeutics Inc.: incorporated in Delaware; business address in Cambridge, Massachusetts; industry Biological Products, (No Diagnostic Substances) (Schedule 13G/A, 2026-08-14).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-08-14 | Ark Investment Management LLC | 9.95% |
| Schedule 13G/A, 2026-08-13 | Farallon Capital Management, L.L.C. | 9.99% |
| Schedule 13G, 2026-04-29 | Vanguard Capital Management | 5.02% |
| Schedule 13G/A, 2026-03-26 | The Vanguard Group | 0% |
| Schedule 13G, 2026-02-09 | State Street Corporation | 5.2% |
| Schedule 13G/A, 2026-02-05 | Fmr LLC | 12.6% |
| Schedule 13G/A, 2026-02-05 | Dapice Joshua J. | 9.99% |
| Schedule 13G/A, 2026-02-03 | Ark Investment Management LLC | 12.29% |
| Schedule 13G/A, 2025-11-05 | Fmr LLC | 13.6% |
| Schedule 13G/A, 2025-08-07 | Ark Investment Management LLC | 10.35% |
| Schedule 13G/A, 2025-08-06 | Fmr LLC | 15% |
Questions about who owns Beam Therapeutics Inc.
Who owns Beam Therapeutics Inc.?
On this page, 6 holders' latest ownership filings report 5% or more of Beam Therapeutics Inc.: Fmr LLC (12.6%, Schedule 13G/A, filed 2026-02-05), Farallon Capital Management, L.L.C. (9.99%, Schedule 13G/A, filed 2026-08-13), Dapice Joshua J. (9.99%, Schedule 13G/A, filed 2026-02-05), Ark Investment Management LLC (9.95%, Schedule 13G/A, filed 2026-08-14) and State Street Corporation (5.2%, Schedule 13G, filed 2026-02-09); 1 more is listed above.
Who are the largest shareholders of Beam Therapeutics Inc.?
By the share each holder's latest filing reports, the largest holders of Beam Therapeutics Inc. on this page are Fmr LLC (12.6%), Farallon Capital Management, L.L.C. (9.99%) and Dapice Joshua J. (9.99%).
When did Fmr LLC buy into Beam Therapeutics Inc.?
The filings give report dates, not purchase dates. The earliest filing from Fmr LLC on this page is the Schedule 13G/A, filed 2025-08-06, reporting 15%; its latest, Schedule 13G/A filed 2026-02-05, reports 12.6%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 11 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Beam Therapeutics Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Beam Therapeutics Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Beam Therapeutics Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
18 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Beam Therapeutics Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- Fidelity (FMR), a 10% owner: 1,695,828 shares (1.6% of shares outstanding), held indirectly through F-Prime Capital Partners Healthcare Fund V LP and 1 other (Form 4, 2026-06-29).
- , the chief executive and a director: 1,150,205 shares (1.1% of shares outstanding), 1,047,205 held directly and 103,000 indirectly (Form 4, 2026-10-16).
- , the president: 253,911 shares (0.25% of shares outstanding), 130,504 held directly and 123,407 indirectly (Form 4, 2026-09-25).
- , the chief legal officer: 109,711 shares (0.11% of shares outstanding) (Form 4, 2026-04-06).
- , the chief financial officer: 105,456 shares (0.10% of shares outstanding) (Form 4, 2026-04-02).
Shares outstanding: 103,495,644 as of 2026-10-27, from the company's latest SEC cover page.
How much has Beam Therapeutics Inc. raised?
Acquisitions reported on Form 8-K, Item 2.01: completed an acquisition (2025-12-11).
Keep reading
More on Beam Therapeutics Inc. and the records around it.
Beam Therapeutics Inc. elsewhere on the record
- 5%+ stake filings Aug 2026
Companies that share a holder
- Farallon Capital Management, L.L.C. also filed stake reports on 18 other companies: EXELIXIS, INC. (Nov 2026), ENANTA PHARMACEUTICALS INC (Aug 2026), InflaRx N.V. (Aug 2026)
- Farallon Capital Partners, L.P. also filed stake reports on 19 other companies: BridgeBio Pharma, Inc. (May 2026), InflaRx N.V. (May 2026), Beta Bionics, Inc. (May 2026)
- ARK Investment Management LLC also filed stake reports on 20 other companies: Tempus AI, Inc. (Nov 2026), 10x Genomics, Inc. (Oct 2026), Twist Bioscience Corp (Sep 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/beam-therapeutics